10/14
10:07 am
tvrd
Rating for TVRD
Medium
Report
Rating for TVRD
10/14
10:07 am
tvrd
Rating for TVRD
Medium
Report
Rating for TVRD
10/14
09:12 am
tvrd
Tvardi Therapeutics (NASDAQ:TVRD) was downgraded by analysts at Raymond James Financial, Inc. from an "outperform" rating to a "market perform" rating.
Medium
Report
Tvardi Therapeutics (NASDAQ:TVRD) was downgraded by analysts at Raymond James Financial, Inc. from an "outperform" rating to a "market perform" rating.
10/14
08:00 am
tvrd
Tvardi Therapeutics (NASDAQ:TVRD) was upgraded by analysts at Barclays PLC to a "strong-buy" rating. They now have a $61.00 price target on the stock.
Low
Report
Tvardi Therapeutics (NASDAQ:TVRD) was upgraded by analysts at Barclays PLC to a "strong-buy" rating. They now have a $61.00 price target on the stock.
10/14
06:56 am
tvrd
Tvardi downgraded to Market Perform from Outperform at Raymond James
Medium
Report
Tvardi downgraded to Market Perform from Outperform at Raymond James
10/14
06:56 am
tvrd
Tvardi downgraded to Market Perform from Outperform at Raymond James
Medium
Report
Tvardi downgraded to Market Perform from Outperform at Raymond James
10/13
04:14 pm
tvrd
Tvardi Therapeutics downgraded to Equal Weight from Overweight at Barclays
Medium
Report
Tvardi Therapeutics downgraded to Equal Weight from Overweight at Barclays
10/13
04:14 pm
tvrd
Tvardi Therapeutics downgraded to Equal Weight from Overweight at Barclays
Medium
Report
Tvardi Therapeutics downgraded to Equal Weight from Overweight at Barclays